Pentacyclic kinase inhibitors
US7749994B2 · kind B2 · utility
0Cited by
0References
17Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 14, 2006 |
| Grant date | Jul 6, 2010 |
| Priority date | — |
| Expiry date | Dec 6, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention provides novel kinase inhibitors that are useful as therapeutic agents for example in the treatment malignancies where the compounds have the general formula Iwherein A, X, Y, Z, Ra, Rb, Rc, R1, R2, R3 and m are defined herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.